215 related articles for article (PubMed ID: 37250022)
21. Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents.
Kim SM; Park JH; Lee KN; Kim SK; Ko YJ; Lee HS; Cho IS
Antiviral Res; 2012 Nov; 96(2):213-20. PubMed ID: 23000495
[TBL] [Abstract][Full Text] [Related]
22. A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design.
Yang D; Sun C; Gao R; Wang H; Liu W; Yu K; Zhou G; Zhao B; Yu L
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493820
[TBL] [Abstract][Full Text] [Related]
23. Novel antiviral therapeutics to control foot-and-mouth disease.
Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
[TBL] [Abstract][Full Text] [Related]
24. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
25. Baculovirus AcMNPV induces type I interferons and NK/NKT cells-mediated protection against foot-and-mouth disease virus in mice.
Molina GN; Cacciabue M; Gismondi MI; Taboga O; Molinari P
Antiviral Res; 2020 Aug; 180():104850. PubMed ID: 32574690
[TBL] [Abstract][Full Text] [Related]
26. Immunoprotective mechanisms in swine within the "grey zone" in antibody response after immunization with foot-and-mouth disease vaccine.
Zhang L; Feng X; Jin Y; Ma J; Cai H; Zhang X
Virus Res; 2016 Jul; 220():39-46. PubMed ID: 27067203
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of Interferon gamma and Interleukin-21 response following foot and mouth disease virus infection.
Sharma AK; Bhatt M; Sankar M; Mohapatra JK; Dash BB; Gowane GR; Subramaniam S; Ranjan R; Pattnaik B
Microb Pathog; 2018 Dec; 125():20-25. PubMed ID: 30145254
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of porcine interferon delta 8 against foot-and-mouth disease virus in vitro.
Li SF; Shao JJ; Zhao FR; Gong MJ; Xie YL; Chang HY; Zhang YG
Int Immunopharmacol; 2018 Jun; 59():47-52. PubMed ID: 29621736
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.
Wu Q; Brum MC; Caron L; Koster M; Grubman MJ
J Interferon Cytokine Res; 2003 Jul; 23(7):359-68. PubMed ID: 14511462
[TBL] [Abstract][Full Text] [Related]
30. Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes TPL2-Mediated Activation of the IRF3/IFN-β Signaling Pathway to Facilitate the Virus Replication.
Hao J; Shen C; Wei N; Yan M; Zhang X; Xu G; Zhang D; Hou J; Cao W; Jin Y; Zhang K; Zheng H; Liu X
Front Immunol; 2020; 11():580334. PubMed ID: 33488582
[TBL] [Abstract][Full Text] [Related]
31. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
[TBL] [Abstract][Full Text] [Related]
32. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Biomed Pharmacother; 2019 Aug; 116():108982. PubMed ID: 31146110
[TBL] [Abstract][Full Text] [Related]
34. Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro.
Zhao FR; Xie YL; Liu ZZ; Shao JJ; Li SF; Zhang YG; Chang HY
J Med Virol; 2017 Nov; 89(11):2041-2046. PubMed ID: 28390158
[TBL] [Abstract][Full Text] [Related]
35. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
[TBL] [Abstract][Full Text] [Related]
36. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
37. Investigation of honey bee venom effect on the immunogenicity of foot-and-mouth disease vaccine in sheep.
Eweis ARF; Hassan KM; Shoman SAH; Taha HA; Mohamed EE
Open Vet J; 2022; 12(6):919-928. PubMed ID: 36650860
[TBL] [Abstract][Full Text] [Related]
38. New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.
Rodríguez-Calvo T; Ojosnegros S; Sanz-Ramos M; García-Arriaza J; Escarmís C; Domingo E; Sevilla N
PLoS One; 2010 Apr; 5(4):e10414. PubMed ID: 20454676
[TBL] [Abstract][Full Text] [Related]
39. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
40. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.
Dias CC; Moraes MP; Segundo FD; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2011 Feb; 31(2):227-36. PubMed ID: 20874428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
